Ambit Biosciences

2 Decision Makers · 2 Verified Contacts

📍 San Diego, CAPharmaceuticals🗓 Est. 2000👥 51–100 employees

About Ambit Biosciences

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

Leadership & Decision Makers

Contact details of 2 Ambit Biosciences decision makers

Alan Lewis

President & CEO

Kevin Kinsella

Founder

General Emails

General company emails, e.g. customer support lines

    sales@ambitbio.com

    Sales Department

Similar Companies like Ambit Biosciences

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Rakuten Medical

rakuten-med.com
Pharmaceuticals · San Diego, CA · Est. 2010 · 101–250 employees

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Indivior

indivior.com
Biotechnology · Richmond, VA · Est. 2014 · 501–1000 employees

HQ: Richmond, VA

Explore similar firms in the Pharmaceuticals sector

Company Info

(858) 334-2100

San Diego, CA

Specialization: Biopharmaceutical,
Acquired by: Daiichi Sankyo
Legal Name: Aventa Biosciences Corp
Business Type: Delisted
Employees: 51-100
Rounds: Venture - Series Unknown
Founded Date: 2000
Company Type: For Profit
Stock Symbol: NASDAQ:AMBI
Operating Status: Active
Last Funding Type: Venture - Series Unknown
Phone Number: (858) 334-2100
Last Investment Activity: Apr 17, 2019
Investments Activity: Apr 17, 2019 Sep 20, 2017 Mar 11, 2016

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.